biostudies-literatureWiedemann MMedical Research CouncilWellcome Truste002732https://www.ebi.ac.uk/biostudies/studies/S-EPMC11664366biostudies-literatureUnknown11(2)<h4>Background</h4>The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England.<h4>Objective</h4>To describe the impact of the pandemic on blood pressure screening and hypertension management based on a national quality of care scheme (Quality and Outcomes Framework, QOF) across key demographic, regional and clinical subgroups.<h4>Methods</h4>With NHS England approval, a population-based cohort study was conducted using OpenSAFELY-TPP on 25.2 million NHS patients registered at general practices (March 2019 to March 2023). We examined monthly changes in recorded blood pressure screening in the preceding 5 years in patients aged ≥45 years and recorded the hypertension prevalence and the percentage of patients treated to target (≤140/90 mmHg for patients aged Open heartImpact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY.PMC11664366MC_PC_20030MC_PC_20058MC_PC_20059222097/Z/20/ZHiggins RParry JAndrews CCunningham CMassey JDillingham ITomlinson LBrown ADSmith RMMaude SGoldacre BMahalingasivam VWiedemann MMacKenna BSpeed VMorley JCurtis HJHopcroft LGreen ARentsch CTHester FMcManus RJMorton CEvans DInglesby PSamuel MWood CMehrkar ABates CFisher LCockburn JWalters CWalker AJBacon SfalseImpact of COVID-19 on recorded blood pressure screening and hypertension management in England: an analysis of monthly changes in the quality and outcomes framework indicators in OpenSAFELY.<h4>Background</h4>The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England.<h4>Objective</h4>To describe the impact of the pandemic on blood pressure screening and hypertension management based on a national quality of care scheme (Quality and Outcomes Framework, QOF) across key demographic, regional and clinical subgroups.<h4>Methods</h4>With NHS England approval, a population-based cohort study was conducted using OpenSAFELY-TPP on 25.2 million NHS patients registered at general practices (March 2019 to March 2023). We examined monthly changes in recorded blood pressure screening in the preceding 5 years in patients aged ≥45 years and recorded the hypertension prevalence and the percentage of patients treated to target (≤140/90 mmHg for patients aged 2024-01-01T00:00:00Z2024 Aug2025-04-04T20:28:36.841Z2025-04-04T20:28:36.841ZS-EPMC116643663921453410.1136/openhrt-2024-002732